Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Standard

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). / Penack, Olaf; Becker, Carolin; Buchheidt, Dieter; Christopeit, Maximilian; Kiehl, Michael; von Lilienfeld-Toal, Marie; Hentrich, Marcus; Reinwald, Marc; Salwender, Hans; Schalk, Enrico; Schmidt-Hieber, Martin; Weber, Thomas; Ostermann, Helmut.

in: ANN HEMATOL, Jahrgang 93, Nr. 7, 01.07.2014, S. 1083-95.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Penack, O, Becker, C, Buchheidt, D, Christopeit, M, Kiehl, M, von Lilienfeld-Toal, M, Hentrich, M, Reinwald, M, Salwender, H, Schalk, E, Schmidt-Hieber, M, Weber, T & Ostermann, H 2014, 'Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)', ANN HEMATOL, Jg. 93, Nr. 7, S. 1083-95. https://doi.org/10.1007/s00277-014-2086-0

APA

Penack, O., Becker, C., Buchheidt, D., Christopeit, M., Kiehl, M., von Lilienfeld-Toal, M., Hentrich, M., Reinwald, M., Salwender, H., Schalk, E., Schmidt-Hieber, M., Weber, T., & Ostermann, H. (2014). Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). ANN HEMATOL, 93(7), 1083-95. https://doi.org/10.1007/s00277-014-2086-0

Vancouver

Bibtex

@article{67d537ca59084695a77f9dd88326fd0d,
title = "Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)",
abstract = "Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optimal management may differ between neutropenic and non-neutropenic patients. Our aim is to give evidence-based recommendations for haematologist, oncologists and intensive care physicians on how to manage adult patients with neutropenia and sepsis.",
keywords = "Communicable Diseases, Disease Management, Germany, Hematology, Humans, Medical Oncology, Neutropenia, Practice Guidelines as Topic, Sepsis, Societies, Medical",
author = "Olaf Penack and Carolin Becker and Dieter Buchheidt and Maximilian Christopeit and Michael Kiehl and {von Lilienfeld-Toal}, Marie and Marcus Hentrich and Marc Reinwald and Hans Salwender and Enrico Schalk and Martin Schmidt-Hieber and Thomas Weber and Helmut Ostermann",
note = "Christopeit, Maximilian ver{\"o}ffentlicht diese Publikation unter [ 4 ] Univ Hosp Martin Luther Univ, Halle, Saale, Germany GUW: kann nicht die letzte Interne Affiliierzung entfernen - Speicherfehler. ",
year = "2014",
month = jul,
day = "1",
doi = "10.1007/s00277-014-2086-0",
language = "English",
volume = "93",
pages = "1083--95",
journal = "ANN HEMATOL",
issn = "0939-5555",
publisher = "Springer",
number = "7",

}

RIS

TY - JOUR

T1 - Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

AU - Penack, Olaf

AU - Becker, Carolin

AU - Buchheidt, Dieter

AU - Christopeit, Maximilian

AU - Kiehl, Michael

AU - von Lilienfeld-Toal, Marie

AU - Hentrich, Marcus

AU - Reinwald, Marc

AU - Salwender, Hans

AU - Schalk, Enrico

AU - Schmidt-Hieber, Martin

AU - Weber, Thomas

AU - Ostermann, Helmut

N1 - Christopeit, Maximilian veröffentlicht diese Publikation unter [ 4 ] Univ Hosp Martin Luther Univ, Halle, Saale, Germany GUW: kann nicht die letzte Interne Affiliierzung entfernen - Speicherfehler.

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optimal management may differ between neutropenic and non-neutropenic patients. Our aim is to give evidence-based recommendations for haematologist, oncologists and intensive care physicians on how to manage adult patients with neutropenia and sepsis.

AB - Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optimal management may differ between neutropenic and non-neutropenic patients. Our aim is to give evidence-based recommendations for haematologist, oncologists and intensive care physicians on how to manage adult patients with neutropenia and sepsis.

KW - Communicable Diseases

KW - Disease Management

KW - Germany

KW - Hematology

KW - Humans

KW - Medical Oncology

KW - Neutropenia

KW - Practice Guidelines as Topic

KW - Sepsis

KW - Societies, Medical

U2 - 10.1007/s00277-014-2086-0

DO - 10.1007/s00277-014-2086-0

M3 - SCORING: Journal article

C2 - 24777705

VL - 93

SP - 1083

EP - 1095

JO - ANN HEMATOL

JF - ANN HEMATOL

SN - 0939-5555

IS - 7

ER -